Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.

Hensley, Lisa E; Stevens, Edward L; Yan, S Betty; Geisbert, Joan B; Macias, William L; Larsen, Tom; Daddario-DiCaprio, Kathleen M; Cassell, Gail H; Jahrling, Peter B; Geisbert, Thomas W

Hensley, Lisa E; Stevens, Edward L; Yan, S Betty; Geisbert, Joan B; Macias, William L; Larsen, Tom; Daddario-DiCaprio, Kathleen M; Cassell, Gail H; Jahrling, Peter B; Geisbert, Thomas W.

Affiliation

Hensley LE; Virology Division, US Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.

J Infect Dis ; 196 Suppl 2: S390-9, 2007 Nov 15.

Article in En | MEDLINE | ID: mdl-17940975

Subject(s)

Ebolavirus/isolation & purification; Hemorrhagic Fever, Ebola/drug therapy; Protein C/therapeutic use; Animals; Catheterization, Central Venous; Disease Models, Animal; Macaca mulatta; Oligopeptides/therapeutic use; Primates; Protein C/administration & dosage; Protein C/genetics; Recombinant Proteins/administration & dosage; Recombinant Proteins/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Protein C / Hemorrhagic Fever, Ebola / Ebolavirus Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Infect Dis Year: 2007 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links